DE60216045D1 - Krebsdiagnoseverfahren - Google Patents

Krebsdiagnoseverfahren

Info

Publication number
DE60216045D1
DE60216045D1 DE60216045T DE60216045T DE60216045D1 DE 60216045 D1 DE60216045 D1 DE 60216045D1 DE 60216045 T DE60216045 T DE 60216045T DE 60216045 T DE60216045 T DE 60216045T DE 60216045 D1 DE60216045 D1 DE 60216045D1
Authority
DE
Germany
Prior art keywords
cells
cyclin
protein
type
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216045T
Other languages
English (en)
Other versions
DE60216045T2 (de
Inventor
Fredrik Erlandsson
Anders Zetterberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60216045D1 publication Critical patent/DE60216045D1/de
Application granted granted Critical
Publication of DE60216045T2 publication Critical patent/DE60216045T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60216045T 2001-01-24 2002-01-24 Krebsdiagnoseverfahren Expired - Lifetime DE60216045T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100197A SE0100197L (sv) 2001-01-24 2001-01-24 Metod för diagnosticering av cancer i vävnad
SE0100197 2001-01-24
PCT/SE2002/000116 WO2002059616A1 (en) 2001-01-24 2002-01-24 Method for cancer diagnostics

Publications (2)

Publication Number Publication Date
DE60216045D1 true DE60216045D1 (de) 2006-12-28
DE60216045T2 DE60216045T2 (de) 2007-07-05

Family

ID=20282710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216045T Expired - Lifetime DE60216045T2 (de) 2001-01-24 2002-01-24 Krebsdiagnoseverfahren

Country Status (10)

Country Link
US (1) US20040115746A1 (de)
EP (1) EP1354210B1 (de)
JP (1) JP2004529322A (de)
CN (1) CN1502044A (de)
AT (1) ATE345503T1 (de)
CA (1) CA2435210A1 (de)
DE (1) DE60216045T2 (de)
ES (1) ES2276922T3 (de)
SE (1) SE0100197L (de)
WO (1) WO2002059616A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429540B (zh) * 2007-11-09 2013-07-10 北京雅康博生物科技有限公司 实时定量pcr检测细胞周期蛋白b2基因表达的方法
CN105122064A (zh) * 2013-01-14 2015-12-02 茵赛德斯有限公司 确定针对子宫颈癌是否应该测试子宫颈细胞样本的方法及用于实施其的装置和试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543291A (en) * 1993-01-29 1996-08-06 Dana Farber Cancer Institute Method of detecting carcinoma

Also Published As

Publication number Publication date
EP1354210B1 (de) 2006-11-15
SE0100197D0 (sv) 2001-01-24
WO2002059616A1 (en) 2002-08-01
SE0100197L (sv) 2002-07-25
US20040115746A1 (en) 2004-06-17
ES2276922T3 (es) 2007-07-01
CN1502044A (zh) 2004-06-02
DE60216045T2 (de) 2007-07-05
ATE345503T1 (de) 2006-12-15
CA2435210A1 (en) 2002-08-01
JP2004529322A (ja) 2004-09-24
EP1354210A1 (de) 2003-10-22

Similar Documents

Publication Publication Date Title
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
DE69907155D1 (de) Krebsbehandlung
EP1474510A4 (de) Zusammensetzungen und verfahren zum nachweis, zur diagnose und zur therapie hämatologischer malignitäten
BR9912007A (pt) Composições e métodos para terapia e diagnóstico de câncer de próstata
CY1116265T1 (el) Kit ραδιοεπισημανσης και προσδιορισμος δεσμευσης
DE69936780D1 (de) Antikörper gegen eine lar-phosphatase untereinheit
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
DE69519796D1 (de) PTPalpha-Bestimmung in der Tumordiagnose und -Prognose
ES2171219T3 (es) Deteccion precoz de cancer de prostata (cap) por determinacion de una relacion entre las concentraciones de antigeno especifico de prostata (psa) y calicreina glandular humana (hgk-1).
TR199902828T2 (xx) Lizofosfolipidlerin de�i�mi� konsantrasyonlar� ile birle�tirilmi� kanser belirleme y�ntemi.
ATE350662T1 (de) Markerproteine für prostatakrebs
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
WO2003025141A3 (en) Genetic analysis for stratification of cancer risk
DE60216045D1 (de) Krebsdiagnoseverfahren
GB9710154D0 (en) Detection of retroviruses
AR029547A1 (es) Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon
BR0209172A (pt) Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método
WO2002063048A3 (en) Methods for predicting sensitivity of tumors to arginine deprivation
Müezzinoğlu et al. Population standards of prostate specific antigen values in men over 40: community based study in Turkey
BR0012301A (pt) Inibidores de crescimento de células epiteliais
FR2849203B1 (fr) Methode d'analyse de l'agressivite tumorale de cellules cancereuses comprenant la mesure de la quantite d'actine polymerisee a l'etat stationnaire
NO20050320L (no) Fremgangsmate for oppregulering av tumor antigen ekspresjon ved thymalfasin
DE60328770D1 (de) Ein neuer biologischer tumormarker und methoden für die detektion des krebsartigen oder nicht krebsartigen phenotyps von zellen
WO2003028539A3 (en) Materials and methods for the diagnosis of pediatric tumors
WO2002084284A3 (en) Diagnosis and treatment of cancer:ii

Legal Events

Date Code Title Description
8364 No opposition during term of opposition